• $15.3M
    Market Cap
  • -89.84%
    1-Year Change
  • Diagnostics & Research
    Industry
Annual
Quarterly
06/30/2025
06/30/2024
06/30/2023
06/30/2022
Income Statement
Total Operating Revenue
4.3M
-42.32%
7.4M
+93.52%
3.8M
+17.93%
3.2M
N/A
Cost of Revenue
91,099
-47.45%
173,349
-70.71%
591,885
-41.11%
1.0M
N/A
Gross Profit
4.2M
-42.19%
7.2M
+123.65%
3.2M
+44.50%
2.2M
N/A
Sales and Marketing Expense
3.6M
-30.28%
5.2M
+62.33%
3.2M
-67.33%
9.8M
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
-76,422
N/A
Depreciation and Amortization Expense
137,290
+34.56%
102,032
+50.63%
67,738
+3.10%
65,700
N/A
Total Operating Expenses
3.6M
-30.28%
5.2M
+777.38%
591,574
-36.29%
928,608
N/A
Operating Profit
552,679
-72.72%
2.0M
+6,829.82%
29,238
+100.39%
-7.6M
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
161,849
+215.89%
-139,656
-6,772.53%
2,093
+131.22%
-6,703
N/A
Income before Taxes
714,528
-62.12%
1.9M
+5,921.15%
31,331
+100.41%
-7.6M
N/A
Income Taxes
222,268
-57.52%
523,207
+5,006.45%
10,246
+550.13%
1,576
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
460,435
-63.33%
1.3M
+5,854.22%
21,085
+100.28%
-7.6M
N/A
Net Income from Continuing Operations Applicable to Common
714,528
-62.12%
1.9M
+4,926.13%
-39,089
-99.48%
-7.5M
N/A
Basic EPS and Net Income
0.02
-64.29%
0.04
+4,300.00%
-0.001
-96.55%
-0.03
N/A
Diluted EPS and Net Income
0.02
-64.29%
0.04
+4,300.00%
-0.001
-96.55%
-0.03
N/A
Basic Weighted Average Shares
30.0M
+0.02%
30.0M
-0.04%
30.0M
-88.28%
256.2M
N/A
Diluted Weighted Average Shares
30.0M
+0.02%
30.0M
-0.04%
30.0M
-88.28%
256.2M
N/A
Balance Sheet
Cash and Cash Equivalents
1.6M
+17.00%
1.4M
+23.53%
1.1M
+218.66%
356,672
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
1.6M
+17.00%
1.4M
+23.53%
1.1M
+218.66%
356,672
N/A
Total Current Assets
1.8M
+9.26%
1.7M
+26.44%
1.3M
+209.38%
424,328
N/A
Accumulated Depreciation
242,588
+63.27%
148,582
+19.87%
123,952
+88.42%
65,786
N/A
Property and Plant and Equipment and Net
280,003
-20.79%
353,486
+131.46%
152,719
+39.81%
109,233
N/A
Total Long-Term Assets
280,003
-20.79%
353,486
+131.46%
152,719
+39.81%
109,233
N/A
Total Assets
2.1M
+3.06%
2.1M
+39.16%
1.5M
+142.81%
610,667
N/A
Income Taxes Payable
222,268
-57.52%
523,207
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
408
N/A
N/A
N/A
N/A
N/A
217,891
N/A
Total Current Liabilities
830,464
-34.31%
1.3M
-38.23%
2.0M
+25.55%
1.6M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
18,570
+1.40%
18,314
+165.77%
6,891
+130.78%
2,986
N/A
Total Liabilities
830,464
-35.25%
1.3M
-37.54%
2.1M
+25.75%
1.6M
N/A
Retained Earnings
-6.2M
-6.95%
-6.6M
-15.92%
-7.9M
+0.50%
-7.8M
N/A
Total Stockholders Equity
1.2M
+68.62%
702,515
+229.63%
-541,957
-41.65%
-928,786
N/A
Total Shares Outstanding
30.0M
+0.03%
30.0M
+0.00003%
30.0M
-90.00%
300.0M
N/A
Cash Flow
Cash from Operating Activities
277,365
-52.37%
582,282
-39.68%
965,337
+3,278.61%
28,572
N/A
Capital Expenditures
59,375
-80.56%
305,495
+154.31%
120,127
+7.37%
111,882
N/A
Cash from Investing Activities
-59,375
-80.56%
-305,495
+142.69%
-125,880
+12.51%
-111,882
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
N/A
N/A
N/A
N/A
-143,333
-179.76%
179,697
N/A
Financials Ratio
Gross Margin
97.86%
+0.21%
97.65%
+15.57%
84.50%
N/A
N/A
N/A
Operating Margin
12.97%
-52.71%
27.42%
+3,480.76%
0.77%
N/A
N/A
N/A
Return on Assets
21.98%
-68.96%
70.81%
+3,414.97%
2.01%
N/A
N/A
N/A
Return on Equity
48.80%
-96.88%
1,563.86%
+54,641.07%
-2.87%
N/A
N/A
N/A
Revenue Growth
-42.32%
-145.25%
93.52%
+421.61%
17.93%
N/A
N/A
N/A
Current Ratio
2.18
+66.33%
1.31
+104.66%
0.64
N/A
N/A
N/A
Cash Ratio
1.98
+78.11%
1.11
+99.96%
0.56
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow